Michael Franken, President, Biosimilars Busines at MOMENTA PHARMACEUTICALS INC (MNTA), sold 20,000 shares at $22.36 ($447K) on 2015-08-10, disclosed to the SEC on 2015-08-14.
Open-market sale of $447k MNTA by President, Biosimilars Busines. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| MNTA | SELL | 2015-06-15 | $11K | — | Filing → |
| MNTA | SELL | 2015-03-13 | $8K | — | Filing → |
| MNTA | SELL | 2014-12-12 | $25K | — | Filing → |